News | Magnetic Resonance Imaging (MRI) | January 26, 2024

InkSpace Imaging gets FDA clearance for its Siemens 3T MRI compatible Small body array 

InkSpace Imaging gets FDA clearance for its Siemens 3T MRI compatible Small body array

January 26, 2024 — InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis. 

The technologically advanced Small Body Array is huggable, lightweight, and flexible. It wraps around patients like a blanket, ensuring unparalleled image quality. The body contouring design optimizes the signal-to-noise ratio, which is crucial for detecting subtle abnormalities often missed by standard rigid, conventional coils. This leap in image quality means quicker and more accurate diagnoses, especially in complex cases. 

This design marks a dramatic shift from conventional coils, as InkSpace Imaging's coils are up to 80 percent lighter and provide a 10-40% faster throughput. The design of the Small Body Array is especially noteworthy for its flexibility which allows it to conform to a wide,e range of patient anatomies and sizes, significantly reducing scan times and minimizing the duration patients need to remain still. This adaptability ensures all patients receive optimal imaging experiences, enhanced patient comfort, and significantly benefits technologists by streamlining the imaging process due to its high coil element density. 

Dr. Peter Fischer, CEO of InkSpace Imaging, stated: "The FDA clearance of InkSpace Imaging's Small Body Array marks a pivotal moment in MRI technology advancement. Our suite of MR coils is a game-changer, offering total freedom in coil positioning and handling. What's truly impressive is how our thin flexible coil contours to each patient's body, offering comfort while enhancing image quality. It's a win-win for patients and healthcare providers alike." 

The FDA clearance of InkSpace Imaging's Small Body Array is a testament to the company's commitment to innovation and improving patient care. This breakthrough technology again sets a new standard in MRI imaging. 


Related Content

News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | PET Imaging

Aug. 14, 2026 — Lantheus Holdings recently announced U.S. Food and Drug Administration (FDA) approval of Tauklarify ...

Time August 20, 2026
arrow
News | PET Imaging

Aug. 18, 2026 — Cortech.AI's NeuroQuant PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET aids ...

Time August 18, 2026
arrow
News | Digital Pathology

Aug.11, 2026 – Leica Biosystems has received multiple U.S. Food and Drug Administration (FDA) 510(k) clearances that ...

Time August 14, 2026
arrow
News | Cardiac Imaging

August 4, 2026 - ASCEND Cardiovascular and Epsilon Imaging have announced a strategic non-exclusive partnership designed ...

Time August 13, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
Subscribe Now